Try
Orthofix Medical Inc. Common Stock (DE)
OFIXUnited States
5 filed reports · 291 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 1,052 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 1,016 | Dec 2025 |
Financial data
291 concepts · 2,068 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial274 concepts · 1,658 facts · Sep 2023 to Jun 2026
- Allowance for doubtful accounts receivable14 · Dec 2023 to Jun 2026
- Stockholders equity (US GAAP)14 · Dec 2023 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value13 · Dec 2023 to Jun 2026
- Cash and cash equivalents at carrying value13 · Dec 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations13 · Dec 2023 to Jun 2026
- Net income loss13 · Dec 2023 to Jun 2026
- Other comprehensive income loss net of tax portion attributable to parent13 · Dec 2023 to Jun 2026
- Restricted cash13 · Dec 2023 to Jun 2026
- Acquisition-related amortization, impairment, and remeasurement (Note 11)12 · Dec 2023 to Jun 2026
- Acquisition-related fair value adjustments12 · Dec 2023 to Jun 2026
- Allocated share based compensation expense12 · Dec 2023 to Jun 2026
- Amortization and impairment of acquired intangibles12 · Dec 2023 to Jun 2026
- Comprehensive income net of tax12 · Dec 2023 to Jun 2026
- Cost of goods and services sold (US GAAP)12 · Dec 2023 to Jun 2026
- Depreciation and amortization12 · Dec 2023 to Jun 2026
- Depreciation depletion and amortization12 · Dec 2023 to Jun 2026
- Estimated sales, general, and administrative expense (benefit)12 · Dec 2023 to Jun 2026
- Foreign currency transaction gain loss before tax12 · Dec 2023 to Jun 2026
- Gain loss related to litigation settlement12 · Dec 2023 to Jun 2026
- Gross profit (US GAAP)12 · Dec 2023 to Jun 2026
- Income tax expense benefit12 · Dec 2023 to Jun 2026
- Interest income expense net12 · Dec 2023 to Jun 2026
- Marketing service fees12 · Dec 2023 to Jun 2026
- Operating income loss12 · Dec 2023 to Jun 2026
Segment15 concepts · 311 facts · Dec 2023 to Jun 2026
- Revenue94 · Dec 2023 to Jun 2026
- Segment Adjusted EBITDA46 · Dec 2023 to Jun 2026
- Depreciation depletion and amortization23 · Dec 2023 to Jun 2026
- Non-GAAP cost of sales23 · Dec 2023 to Jun 2026
- Non-GAAP Depreciation, amortization, and share-based compensation expense23 · Dec 2023 to Jun 2026
- Non-GAAP Research and development23 · Dec 2023 to Jun 2026
- Non-GAAP Sales, general, and administrative23 · Dec 2023 to Jun 2026
- Other segment expenses (benefits)23 · Dec 2023 to Jun 2026
- Change16 · Jun 2025 to Jun 2026
- Percent of Total Net Sales12 · Dec 2023 to Dec 2025
- Accumulated impairment loss, Currency translation adjustment1 · Dec 2025
- Goodwill gross, Currency translation adjustment1 · Dec 2025
- Goodwill impairment loss1 · Dec 2025
- Marketing service fee as percentage of segment revenues1 · Dec 2025
- Marketing service fees1 · Dec 2025
Geography1 concepts · 96 facts · Dec 2023 to Jun 2026
- Revenue96 · Dec 2023 to Jun 2026
Product1 concepts · 3 facts · Dec 2023 to Dec 2025
- Cost of goods and services sold (US GAAP)3 · Dec 2023 to Dec 2025
Segments
410 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments4 members · 272 facts
- Global Spine140 · Dec 2023 to Jun 2026
- Global Limb Reconstruction84 · Dec 2023 to Jun 2026
- Global Orthopedics46 · Jun 2024 to Sep 2025
- Biologics2 · Dec 2025
Statement geographical8 members · 96 facts
- BR12 · Dec 2023 to Jun 2026
- DE12 · Dec 2023 to Jun 2026
- FR12 · Dec 2023 to Jun 2026
- GB12 · Dec 2023 to Jun 2026
- IT12 · Dec 2023 to Jun 2026
- Non Us12 · Dec 2023 to Jun 2026
- Other Countries12 · Dec 2023 to Jun 2026
- US12 · Dec 2023 to Jun 2026
Subsegments3 members · 39 facts
- Spinal Implants Biologics And Enabling Technologies19 · Dec 2023 to Jun 2026
- Bone Growth Therapies14 · Dec 2023 to Dec 2025
- Therapeutic Solutions6 · Mar 2025 to Jun 2026
Product or service1 member · 3 facts
- Shipping And Handling3 · Dec 2023 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Nov 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 5, 2026
- FY2026 Q1May 5, 2026
- FY2025 Q4Feb 24, 2026
- FY2025 Q3Nov 4, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.